BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24939416)

  • 21. CYP1A1, cigarette smoking, and colon and rectal cancer.
    Slattery ML; Samowtiz W; Ma K; Murtaugh M; Sweeney C; Levin TR; Neuhausen S
    Am J Epidemiol; 2004 Nov; 160(9):842-52. PubMed ID: 15496536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer.
    Liu HX; Li J; Ye BG
    Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction.
    Khlifi R; Ben Salah G; Chakroun A; Hamza-Chaffai A; Rebai A
    Mol Biol Rep; 2014 Sep; 41(9):5735-43. PubMed ID: 24934312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
    Sun K; Gong A; Liang P
    Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Contribution of Excision Repair Cross-complementing Group 1 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
    Yueh TC; Chou AK; Gong CL; Fu CK; Pei JS; Wu MH; Tsai CW; Chang WS; Hsiao CL; Yen ST; Li HT; Bau DT
    Anticancer Res; 2017 May; 37(5):2307-2313. PubMed ID: 28476796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population.
    Dai Q; Luo H; Li XP; Huang J; Zhou TJ; Yang ZH
    Mutagenesis; 2015 May; 30(3):441-9. PubMed ID: 25690281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
    Fan W; Huang Z; Xiao Z; Li S; Ma Q
    J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
    Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population.
    Saeed HM; Alanazi MS; Nounou HA; Salaby MA; Semlali A; Azzam N; Aljebreen A; Alharby O; Parine NR; Shaik J; Arafaha M
    Asian Pac J Cancer Prev; 2013; 14(6):3761-8. PubMed ID: 23886179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India.
    Varma A; Mathaiyan J; Shewade D; Dubashi B; Sunitha K
    J Clin Pharm Ther; 2020 Aug; 45(4):617-627. PubMed ID: 32399998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
    Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
    Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking, the xenobiotic pathway, and clubfoot.
    Sommer A; Blanton SH; Weymouth K; Alvarez C; Richards BS; Barnes D; Hecht JT
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):20-8. PubMed ID: 21254355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer.
    Gil J; Ramsey D; Stembalska A; Karpinski P; Pesz KA; Laczmanska I; Leszczynski P; Grzebieniak Z; Sasiadek MM
    Mol Biol Rep; 2012 Jan; 39(1):527-34. PubMed ID: 21559836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
    Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S
    BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
    Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
    J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE frequency.
    Laczmanska I; Gil J; Karpinski P; Stembalska A; Kozlowska J; Busza H; Trusewicz A; Pesz K; Ramsey D; Schlade-Bartusiak K; Blin N; Sasiadek MM
    Environ Mol Mutagen; 2006 Dec; 47(9):666-73. PubMed ID: 17078101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between genetic polymorphism of CYP1A1 at codon 462 (Ile462Val) in colorectal cancer.
    Pereira Serafim PV; Cotrim Guerreiro da Silva ID; Manoukias Forones N
    Int J Biol Markers; 2008; 23(1):18-23. PubMed ID: 18409146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.
    da Silva TD; Felipe AV; de Lima JM; Oshima CT; Forones NM
    World J Gastroenterol; 2011 Feb; 17(6):760-5. PubMed ID: 21390146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.